np_gilmore
TL3 Nurse practitioner · Perth, AU
Nurse practitioner in a metabolic clinic. Injection technique, site rotation, and the practical side of adherence.
Joined 22 January 2025 · last posted 6h · groups: clinicians, wiki-editors
134 posts, newest first. Showing up to 150.
-
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Replied, post #3 · Devices › Pens & autoinjectors · 28 Jul 2026 · 3 likes Coming back to the opening post, because the follow-up matters more than the original answer. Visibility of the dose: some pens allow you to see the insulin remaining;…
-
Follow-up: Reading an interaction checker output critically Replied, post #52 · Practice › Interactions · 18 Jul 2026 · 0 likes Coming back to post #50, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #8 · Clinical › Prescriber conversations · 17 Jul 2026 · 12 likes post #7 is right about the mechanism and I think understates the practical bit. Questions about dose: asking "how will we determine whether this dose is working for me"…
-
What is genuinely unknown about long-term amylin agonism Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #5 · Clinical › Bloodwork · 15 Jul 2026 · 2 likes I read post #3 twice before replying, because I had assumed the opposite. A single value outside interval: usually uninformative on a single draw. What makes a result…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #71 · Analytics › Home & field testing · 12 Jul 2026 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #44 · Clinical › Comorbidities · 12 Jul 2026 · 12 likes Worth separating two things that post #40 runs together. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without…
-
Reading a home test result without over-claiming Replied, post #109 · Analytics › Home & field testing · 7 Jul 2026 · 4 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #28 · Practice › Side effects · 3 Jul 2026 · 7 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #109 · Evidence › Journal club · 3 Jul 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #63 · Analytics › Impurities & related substances · 1 Jul 2026 · 3 likes This follows post #60 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Sulfonylureas: the interaction most worth taking seriously — what changed since Replied, post #4 · Practice › Interactions · 1 Jul 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Submitting a sample: the process end to end Replied, post #46 · Sourcing › Independent verification · 29 Jun 2026 · 23 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Asking a follow-up: new topic or new reply? Replied, post #28 · Start Here › How to Ask · 28 Jun 2026 · 5 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #29 · Access › International · 22 Jun 2026 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Revisiting: The best-written scientific paper you have read Replied, post #42 · Lounge › Off topic · 20 Jun 2026 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
An 18-month record including the parts that went badly Replied, post #46 · Outcomes › Progress reports · 20 Jun 2026 · 6 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Prescription requirements and telehealth models — a second dataset Replied, post #68 · Sourcing › Regulatory · 16 Jun 2026 · 0 likes I read post #66 twice before replying, because I had assumed the opposite. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical…
-
Asking a follow-up: new topic or new reply? Replied, post #11 · Start Here › How to Ask · 15 Jun 2026 · 9 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #25 · Pharmacology › Pharmacokinetics · 14 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #81 · Access › Insurance & coverage · 11 Jun 2026 · 9 likes On post #77 — agreed on the reasoning, with one qualification. Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #120 · Practice › Storage & stability · 10 Jun 2026 · 1 like Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Forced degradation studies: designing one that is informative Replied, post #71 · Analytics › Method validation · 6 Jun 2026 · 13 likes On post #67 — agreed on the reasoning, with one qualification. Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab…
-
Prescription requirements and telehealth models — a second dataset Replied, post #55 · Sourcing › Regulatory · 6 Jun 2026 · 0 likes On post #51 — agreed on the reasoning, with one qualification. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #61 · Sourcing › Red flags · 5 Jun 2026 · 1 like Worth separating two things that post #57 runs together. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #70 · Compounds › Semaglutide · 3 Jun 2026 · 0 likes Picking up post #67: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
-
Recording a dissent on a document rather than suppressing it Replied, post #18 · Documentation › Doc review · 3 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #3 · Research Methods › N-of-1 designs · 31 May 2026 · 12 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #3 · Evidence › Trials · 29 May 2026 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Confounding in observational data: a third variable can explain an apparent association.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #19 · Sourcing › Independent verification · 27 May 2026 · 18 likes Worth separating two things that post #15 runs together. How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity,…
-
Coming back to: Time to steady state after a dose increase Replied, post #58 · Pharmacology › Pharmacokinetics · 21 May 2026 · 27 likes Coming back to post #56, because the follow-up matters more than the original answer. Albumin binding: semaglutide binds albumin through a fatty side chain, which…
-
Designing a personal experiment that could change your mind — one year on Replied, post #49 · Research Methods › N-of-1 designs · 21 May 2026 · 0 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #47 · Devices › Syringes & needles · 21 May 2026 · 0 likes Coming back to post #45, because the follow-up matters more than the original answer. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #20 · Analytics › Method validation · 13 May 2026 · 0 likes post #19 answers the question as asked. The question underneath it is different. Linearity: the detector response is proportional to compound concentration across the…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #41 · Clinical › Comorbidities · 1 May 2026 · 4 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #117 · Practice › Reconstitution · 25 Apr 2026 · 9 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #47 · Practice › Administration · 20 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Official shortage notices and what they authorise Replied, post #4 · Access › Shortages · 11 Apr 2026 · 6 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Spike-and-recover accuracy for a peptide assay Replied, post #9 · Analytics › Method validation · 6 Apr 2026 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #14 · Data & Tools › Calculators · 2 Apr 2026 · 12 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #65 · Practice › Interactions · 28 Mar 2026 · 3 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #21 · Evidence › Journal club · 21 Mar 2026 · 31 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Grapefruit: why this class is not the class that cares Replied, post #50 · Practice › Interactions · 17 Mar 2026 · 0 likes This follows post #47 rather than contradicting it. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #79 · Regional › UK & Ireland · 16 Mar 2026 · 4 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #45 · Compounds › Repair & healing peptides · 12 Mar 2026 · 15 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Measurement error in a self-reported exposure Replied, post #40 · Evidence › Study critique · 23 Feb 2026 · 4 likes post #39 is right about the mechanism and I think understates the practical bit. Choosing the worst interpretation: "The confidence interval includes a harmful effect"…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #90 · Wellbeing › Mental health · 12 Feb 2026 · 0 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #61 · Practice › Storage & stability · 11 Feb 2026 · 0 likes post #60 answers the question as asked. The question underneath it is different. Temperature excursions: if a vial sat at room temperature for a time, the question is…
-
Adsorption to container surfaces and to plastics Replied, post #15 · Pharmacology › Formulation chemistry · 5 Feb 2026 · 0 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…
-
The headache that turns out to be dehydration Replied, post #152 · Nutrition & Training › Hydration & electrolytes · 24 Jan 2026 · 19 likes This follows post #149 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it…
-
Temperature loggers worth the money — the long version Replied, post #109 · Devices › Cold chain · 9 Jan 2026 · 1 like Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
-
Revisiting: Sample handling between despatch and injection Replied, post #5 · Analytics › Method validation · 8 Jan 2026 · 30 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #4 · Practice › Reconstitution · 7 Jan 2026 · 2 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #79 · Practice › Interactions · 30 Dec 2025 · 0 likes Worth separating two things that post #75 runs together. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side…
-
The headache that turns out to be dehydration Replied, post #116 · Nutrition & Training › Hydration & electrolytes · 30 Dec 2025 · 25 likes This follows post #113 rather than contradicting it. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance.…
-
Prescription requirements and telehealth models Replied, post #72 · Sourcing › Regulatory · 17 Dec 2025 · 6 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
The decimal-point error, and the habit that catches it Replied, post #3 · Practice › Reconstitution · 13 Dec 2025 · 6 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
DXA precision and the least significant change for lean mass Replied, post #65 · Outcomes › Body composition · 13 Dec 2025 · 15 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Reading SURMOUNT-1 without the press release Replied, post #98 · Compounds › Tirzepatide · 12 Dec 2025 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Tracking a preprint to publication: a worked example Replied, post #101 · Evidence › Preprints · 10 Dec 2025 · 4 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #29 · Pharmacology › Pharmacokinetics · 1 Dec 2025 · 3 likes I read post #27 twice before replying, because I had assumed the opposite. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate…
-
Pen dose counters: what a click does and does not guarantee Replied, post #27 · Devices › Pens & autoinjectors · 14 Nov 2025 · 8 likes This follows post #24 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Availability by country, dated, with primary sources Replied, post #52 · Access › International · 9 Nov 2025 · 7 likes post #51 answers the question as asked. The question underneath it is different. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
-
Persistent vomiting and the threshold for seeking help Replied, post #65 · Safety › Adverse events · 8 Nov 2025 · 0 likes post #64 answers the question as asked. The question underneath it is different. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back…
-
When to stop reading forums, including this one Replied, post #41 · Wellbeing › Mental health · 26 Oct 2025 · 1 like Coming back to post #39, because the follow-up matters more than the original answer. Identity and self-image: for some people, weight and body size are central to…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #13 · Compounds › Tirzepatide · 19 Oct 2025 · 28 likes Worth separating two things that post #9 runs together. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #92 · Practice › Storage & stability · 12 Oct 2025 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #67 · Practice › Storage & stability · 4 Oct 2025 · 17 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #66 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 4 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Hypertension improvement and when medication needs revisiting Replied, post #75 · Clinical › Comorbidities · 22 Sep 2025 · 19 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Needle changes between doses on a reusable pen Replied, post #35 · Devices › Pens & autoinjectors · 14 Sep 2025 · 0 likes On post #31 — agreed on the reasoning, with one qualification. Needle installation: some pens require a fresh needle for each injection; others have a single needle…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #10 · Practice › Interactions · 31 Aug 2025 · 26 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #33 · Pharmacology › Receptor biology · 30 Aug 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Which panel is worth repeating and which is worth ignoring Replied, post #95 · Clinical › Bloodwork · 27 Aug 2025 · 7 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Triple agonism: additive, synergistic, or neither? Replied, post #81 · Compounds › Retatrutide · 19 Aug 2025 · 2 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #71 · Compounds › Secretagogues & GH axis · 17 Aug 2025 · 0 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #2 · Compounds › Retatrutide · 14 Aug 2025 · 15 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Asking about a compound your prescriber has not heard of Replied, post #119 · Clinical › Prescriber conversations · 8 Aug 2025 · 23 likes Coming back to post #117, because the follow-up matters more than the original answer. Questions about dose: asking "how will we determine whether this dose is working…
-
Titles that describe the question, not the situation Replied, post #62 · Start Here › How to Ask · 2 Aug 2025 · 0 likes Picking up post #59: that is the part I would want checked first. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room…
-
Comparing my trajectory with the trial curves, carefully Replied, post #31 · Outcomes › Progress reports · 2 Aug 2025 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
A ten-fold dose error caught before injection — one year on Replied, post #21 · Devices › Syringes & needles · 1 Aug 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #45 · Analytics › Home & field testing · 31 Jul 2025 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Are there stupid questions here? A staff answer, at length Replied, post #24 · Start Here › Welcome · 30 Jul 2025 · 0 likes This follows post #21 rather than contradicting it. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters…
-
When a preprint is the best available evidence and we say so Replied, post #6 · Evidence › Preprints · 28 Jul 2025 · 6 likes On post #2 — agreed on the reasoning, with one qualification. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are…
-
Are there stupid questions here? A staff answer, at length Replied, post #15 · Start Here › Welcome · 26 Jul 2025 · 20 likes post #14 is right about the mechanism and I think understates the practical bit. Marked solutions are the site's way of saying that someone asked a good question and…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #31 · Practice › Dosing & titration · 21 Jul 2025 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Guidelines revision: what changed and why — one year on Started this topic · Meta › Announcements · 11 Jul 2025 · 2 likes On the subject in the title: Guidelines revision: what changed and why — one year on Working notes rather than a conclusion. Process question about how this site works.…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #16 · Compounds › Repair & healing peptides · 6 Jul 2025 · 1 like I read post #14 twice before replying, because I had assumed the opposite. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from…
-
Repeatability versus intermediate precision Replied, post #113 · Analytics › Method validation · 1 Jul 2025 · 18 likes Coming back to post #111, because the follow-up matters more than the original answer. Limits of detection and quantitation: LOD is the lowest concentration that…
-
Triple agonism: additive, synergistic, or neither? Replied, post #62 · Compounds › Retatrutide · 29 Jun 2025 · 24 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #118 · Compounds › Tirzepatide · 23 Jun 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #72 · Compounds › Retatrutide · 18 Jun 2025 · 0 likes Worth separating two things that post #68 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Research-use-only labelling: what it means and what it does not Replied, post #4 · Sourcing › Regulatory · 17 Jun 2025 · 29 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #44 · Compounds › Oral incretins · 8 Jun 2025 · 5 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Coming back to: Official shortage notices and what they authorise Replied, post #19 · Access › Shortages · 1 Jun 2025 · 16 likes post #18 answers the question as asked. The question underneath it is different. International supply chains: a shortage in one country does not mean shortage in…
-
Merging two pages that cover the same ground Started this topic · Documentation › Wiki requests · 28 May 2025 · 43 likes Merging two pages that cover the same ground Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #101 · Sourcing › Red flags · 25 May 2025 · 3 likes On post #97 — agreed on the reasoning, with one qualification. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #121 · Evidence › Journal club · 21 May 2025 · 4 likes This follows post #118 rather than contradicting it. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question?…
-
Residual solvents and scavengers: what is looked for Replied, post #21 · Analytics › Impurities & related substances · 8 May 2025 · 1 like Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
-
[2026 update] Splitting an overlong document into two Started this topic · Documentation › Wiki requests · 21 Apr 2025 · 0 likes Splitting an overlong document into two — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #80 · Evidence › Journal club · 21 Apr 2025 · 15 likes This follows post #77 rather than contradicting it. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #13 · Devices › Syringes & needles · 17 Apr 2025 · 19 likes post #12 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #11 · Clinical › Comorbidities · 31 Mar 2025 · 8 likes Coming back to post #9, because the follow-up matters more than the original answer. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #42 · Analytics › COA interpretation · 2 Mar 2025 · 2 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #14 · Documentation › Doc review · 7 Feb 2025 · 7 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #75 · Compounds › Other compounds · 28 Jan 2025 · 20 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] New subcategory: rationale and scope Replied, post #153 · Meta › Announcements · 16 Jan 2025 · 0 likes I read post #151 twice before replying, because I had assumed the opposite. Questions welcomed: if an announcement is unclear, asking for clarification is welcome.…
-
Follow-up: Individual participant data versus aggregate data Replied, post #106 · Evidence › Meta-analyses · 12 Jan 2025 · 0 likes I read post #104 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #4 · Meta › Wiki maintenance · 2 Jan 2025 · 3 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #94 · Compounds › Tirzepatide · 2 Jan 2025 · 3 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #90 · Compounds › Oral incretins · 28 Dec 2024 · 1 like post #89 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Building a sensible monitoring schedule with your prescriber Replied, post #33 · Clinical › Bloodwork · 19 Dec 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Body image changing more slowly than the body Replied, post #15 · Wellbeing › Mental health · 12 Dec 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Two sessions a week versus four: what the evidence supports Replied, post #23 · Nutrition & Training › Resistance training · 4 Dec 2024 · 3 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #22 · Evidence › Journal club · 2 Dec 2024 · 17 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Follow-up: The topic list is dense — is that deliberate? Started this topic · Meta › Site feedback · 29 Nov 2024 · 11 likes The question in the title: The topic list is dense — is that deliberate? I will give what I have already checked below so nobody repeats it. Nominating something for…
-
[2026 update] New subcategory: rationale and scope Replied, post #12 · Meta › Announcements · 19 Nov 2024 · 2 likes Coming back to post #10, because the follow-up matters more than the original answer. RSS: if you prefer to receive announcements by feed rather than visiting the site,…
-
EMA product information as a primary source — does this still hold? Replied, post #20 · Regional › European Union · 15 Nov 2024 · 9 likes I read post #18 twice before replying, because I had assumed the opposite. Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #3 · Compounds › Repair & healing peptides · 13 Nov 2024 · 2 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #39 · Clinical › Prescriber conversations · 7 Nov 2024 · 15 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Time to steady state after a dose increase Replied, post #161 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes On post #157 — agreed on the reasoning, with one qualification. Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #22 · Sourcing › Regulatory · 6 Nov 2024 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Merging two pages that cover the same ground — the long version Replied, post #8 · Documentation › Wiki requests · 23 Oct 2024 · 10 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #36 · Clinical › Comorbidities · 14 Oct 2024 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Requesting a page: what makes a good request — what changed since Replied, post #131 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Identical chromatograms across two different lots Replied, post #30 · Sourcing › Red flags · 27 Sep 2024 · 5 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #45 · Clinical › Bloodwork · 21 Sep 2024 · 23 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Progressive overload when the scale is falling — one year on Replied, post #62 · Nutrition & Training › Resistance training · 16 Sep 2024 · 6 likes post #61 is right about the mechanism and I think understates the practical bit. Cardio and resistance: the interaction between energy-intense cardiovascular training…
-
Coming back to: Renal impairment: what the labelling says about dose Started this topic · Clinical › Special populations · 21 Aug 2024 · 1 like Renal impairment: what the labelling says about dose — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a…
-
Correlation in a self-tracked dataset: what it can support Replied, post #36 · Research Methods › Statistics · 21 Aug 2024 · 22 likes Worth separating two things that post #32 runs together. Regression to the mean: if you select people with extreme values (very high or very low), their next…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #46 · Analytics › COA interpretation · 11 Aug 2024 · 0 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
High-resolution MS on aggregates and what it can see — one year on Started this topic · Analytics › Mass spectrometry · 8 Aug 2024 · 0 likes High-resolution MS on aggregates and what it can see — one year on Writing it up because I had to work it out twice and would rather nobody else did. Working through…
-
Blind submission and why it changes minds Replied, post #3 · marked as the solution · Sourcing › Independent verification · 22 Jun 2024 · 7 likes On the opening post — agreed on the reasoning, with one qualification. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #6 · Practice › Dosing & titration · 28 May 2024 · 13 likes post #5 answers the question as asked. The question underneath it is different. Dose equivalence between different incretin analogues is a weak concept. The molecules…